| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Rituximab maintenance for the treatment of patients with follicular lymphoma: systematic review and meta-analysis of randomized trials.
|
J Natl Cancer Inst
|
2009
|
3.83
|
|
2
|
Systematic comparison of four sources of drug information regarding adjustment of dose for renal function.
|
BMJ
|
2005
|
3.51
|
|
3
|
Meta-analysis: antibiotic prophylaxis reduces mortality in neutropenic patients.
|
Ann Intern Med
|
2005
|
3.10
|
|
4
|
Efficacy and safety of cefepime: a systematic review and meta-analysis.
|
Lancet Infect Dis
|
2007
|
3.09
|
|
5
|
Efficacy and safety of tigecycline: a systematic review and meta-analysis.
|
J Antimicrob Chemother
|
2011
|
2.86
|
|
6
|
Comparative meta-analysis of the effect of Lactobacillus species on weight gain in humans and animals.
|
Microb Pathog
|
2012
|
2.85
|
|
7
|
Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis.
|
Antimicrob Agents Chemother
|
2010
|
2.34
|
|
8
|
Typhoid fever vaccines: systematic review and meta-analysis of randomised controlled trials.
|
Vaccine
|
2007
|
2.14
|
|
9
|
Dose-dense chemotherapy in nonmetastatic breast cancer: a systematic review and meta-analysis of randomized controlled trials.
|
J Natl Cancer Inst
|
2010
|
1.99
|
|
10
|
Improving empirical antibiotic treatment using TREAT, a computerized decision support system: cluster randomized trial.
|
J Antimicrob Chemother
|
2006
|
1.88
|
|
11
|
Empirical antibiotic monotherapy for febrile neutropenia: systematic review and meta-analysis of randomized controlled trials.
|
J Antimicrob Chemother
|
2005
|
1.88
|
|
12
|
Antifungal prophylaxis in cancer patients after chemotherapy or hematopoietic stem-cell transplantation: systematic review and meta-analysis.
|
J Clin Oncol
|
2007
|
1.82
|
|
13
|
Prophylactic antibiotics for burns patients: systematic review and meta-analysis.
|
BMJ
|
2010
|
1.78
|
|
14
|
Prophylaxis of Pneumocystis pneumonia in immunocompromised non-HIV-infected patients: systematic review and meta-analysis of randomized controlled trials.
|
Mayo Clin Proc
|
2007
|
1.73
|
|
15
|
Treatment of human brucellosis: systematic review and meta-analysis of randomised controlled trials.
|
BMJ
|
2008
|
1.73
|
|
16
|
Interventions for alleviating cancer-related dyspnea: a systematic review.
|
J Clin Oncol
|
2008
|
1.72
|
|
17
|
Importance of appropriate empirical antibiotic therapy for methicillin-resistant Staphylococcus aureus bacteraemia.
|
J Antimicrob Chemother
|
2010
|
1.71
|
|
18
|
Thyroxine-triiodothyronine combination therapy versus thyroxine monotherapy for clinical hypothyroidism: meta-analysis of randomized controlled trials.
|
J Clin Endocrinol Metab
|
2006
|
1.69
|
|
19
|
Empirical atypical coverage for inpatients with community-acquired pneumonia: systematic review of randomized controlled trials.
|
Arch Intern Med
|
2005
|
1.67
|
|
20
|
Antibiotic prophylaxis in cardiac surgery: systematic review and meta-analysis.
|
J Antimicrob Chemother
|
2011
|
1.67
|
|
21
|
Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials.
|
BMJ
|
2004
|
1.62
|
|
22
|
PCR diagnosis of invasive candidiasis: systematic review and meta-analysis.
|
J Clin Microbiol
|
2010
|
1.59
|
|
23
|
Influenza vaccines in immunosuppressed adults with cancer.
|
Cochrane Database Syst Rev
|
2013
|
1.56
|
|
24
|
Pharmacological interventions for fertility preservation during chemotherapy: a systematic review and meta-analysis.
|
Breast Cancer Res Treat
|
2010
|
1.53
|
|
25
|
Immunoglobulin prophylaxis in hematopoietic stem cell transplantation: systematic review and meta-analysis.
|
J Clin Oncol
|
2008
|
1.52
|
|
26
|
Clinical implications of β-lactam-aminoglycoside synergism: systematic review of randomised trials.
|
Int J Antimicrob Agents
|
2011
|
1.51
|
|
27
|
Comparative efficacy and safety of vancomycin versus teicoplanin: systematic review and meta-analysis.
|
Antimicrob Agents Chemother
|
2009
|
1.47
|
|
28
|
Antimicrobial lock solutions for the prevention of infections associated with intravascular catheters in patients undergoing hemodialysis: systematic review and meta-analysis of randomized, controlled trials.
|
Clin Infect Dis
|
2008
|
1.45
|
|
29
|
Applying an artificial neural network to warfarin maintenance dose prediction.
|
Isr Med Assoc J
|
2004
|
1.43
|
|
30
|
Antibiotic prophylaxis in neutropenic patients.
|
Isr Med Assoc J
|
2007
|
1.43
|
|
31
|
Infective endocarditis in diabetic and non-diabetic patients.
|
Scand J Infect Dis
|
2004
|
1.42
|
|
32
|
Intravenous versus oral iron supplementation for the treatment of anemia in CKD: systematic review and meta-analysis.
|
Am J Kidney Dis
|
2008
|
1.42
|
|
33
|
Effectiveness and safety of colistin: prospective comparative cohort study.
|
J Antimicrob Chemother
|
2010
|
1.42
|
|
34
|
Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for fever with neutropenia: systematic review and meta-analysis.
|
BMJ
|
2003
|
1.35
|
|
35
|
Systematic review and meta-analysis of in vitro synergy of polymyxins and carbapenems.
|
Antimicrob Agents Chemother
|
2013
|
1.27
|
|
36
|
Benefit of appropriate empirical antibiotic treatment: thirty-day mortality and duration of hospital stay.
|
Am J Med
|
2006
|
1.25
|
|
37
|
Treatment modalities for Graves' ophthalmopathy: systematic review and metaanalysis.
|
J Clin Endocrinol Metab
|
2009
|
1.24
|
|
38
|
Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy.
|
Cochrane Database Syst Rev
|
2012
|
1.22
|
|
39
|
The impact of Bevacizumab (Avastin) on survival in metastatic solid tumors--a meta-analysis and systematic review.
|
PLoS One
|
2013
|
1.20
|
|
40
|
A model for diagnosis of pulmonary infections in solid-organ transplant recipients.
|
Comput Methods Programs Biomed
|
2010
|
1.19
|
|
41
|
Vasopressin receptor antagonists for the treatment of hyponatremia: systematic review and meta-analysis.
|
Am J Kidney Dis
|
2010
|
1.19
|
|
42
|
Empirical antibiotics against Gram-positive infections for febrile neutropenia: systematic review and meta-analysis of randomized controlled trials.
|
J Antimicrob Chemother
|
2005
|
1.14
|
|
43
|
Efficacy and safety of aminoglycoside monotherapy: systematic review and meta-analysis of randomized controlled trials.
|
J Antimicrob Chemother
|
2007
|
1.11
|
|
44
|
Vaccines for preventing typhoid fever.
|
Cochrane Database Syst Rev
|
2014
|
1.11
|
|
45
|
Antimicrobial agents for treating uncomplicated urinary tract infection in women.
|
Cochrane Database Syst Rev
|
2010
|
1.10
|
|
46
|
Medicalisation: peering from inside medicine.
|
BMJ
|
2002
|
1.09
|
|
47
|
Intravenous iron supplementation for the treatment of chemotherapy-induced anaemia - systematic review and meta-analysis of randomised controlled trials.
|
Acta Oncol
|
2012
|
1.04
|
|
48
|
Three-day vs longer duration of antibiotic treatment for cystitis in women: systematic review and meta-analysis.
|
Am J Med
|
2005
|
1.04
|
|
49
|
Treatment of invasive candidal infections: systematic review and meta-analysis.
|
Mayo Clin Proc
|
2008
|
1.03
|
|
50
|
Risk factors and a clinical index for diagnosis of Pseudomonas aeruginosa bacteremia.
|
Clin Microbiol Infect
|
1995
|
1.03
|
|
51
|
Effect of quinolone prophylaxis in afebrile neutropenic patients on microbial resistance: systematic review and meta-analysis.
|
J Antimicrob Chemother
|
2006
|
1.03
|
|
52
|
Co-trimoxazole-sensitive, methicillin-resistant Staphylococcus aureus, Israel, 1988-1997.
|
Emerg Infect Dis
|
2003
|
1.01
|
|
53
|
Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis.
|
Cochrane Database Syst Rev
|
2014
|
1.01
|
|
54
|
Reporting of adverse events in randomized controlled trials of highly active antiretroviral therapy: systematic review.
|
J Antimicrob Chemother
|
2009
|
1.00
|
|
55
|
Iron supplementation for the treatment of chronic heart failure and iron deficiency: systematic review and meta-analysis.
|
Eur J Heart Fail
|
2012
|
1.00
|
|
56
|
Benefit of early treatment with oseltamivir in hospitalized patients with documented 2009 influenza A (H1N1): retrospective cohort study.
|
J Antimicrob Chemother
|
2011
|
1.00
|
|
57
|
Thrombocytopenia in Staphylococcus aureus bacteremia: risk factors and prognostic importance.
|
Mayo Clin Proc
|
2011
|
0.99
|
|
58
|
PCR using blood for diagnosis of invasive pneumococcal disease: systematic review and meta-analysis.
|
J Clin Microbiol
|
2009
|
0.99
|
|
59
|
Immunoglobulin prophylaxis in chronic lymphocytic leukemia and multiple myeloma: systematic review and meta-analysis.
|
Leuk Lymphoma
|
2009
|
0.99
|
|
60
|
Treatment of anemia in inflammatory bowel disease--systematic review and meta-analysis.
|
PLoS One
|
2013
|
0.99
|
|
61
|
Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients.
|
Cochrane Database Syst Rev
|
2014
|
0.96
|
|
62
|
Duration of antibiotic treatment for acute pyelonephritis and septic urinary tract infection-- 7 days or less versus longer treatment: systematic review and meta-analysis of randomized controlled trials.
|
J Antimicrob Chemother
|
2013
|
0.95
|
|
63
|
Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients.
|
Cochrane Database Syst Rev
|
2013
|
0.94
|
|
64
|
Combination antibiotic therapy for Pseudomonas aeruginosa bacteraemia.
|
Lancet Infect Dis
|
2005
|
0.94
|
|
65
|
Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients: a systematic review and meta-analysis of randomized trials.
|
J Antimicrob Chemother
|
2004
|
0.93
|
|
66
|
Anti-pseudomonal beta-lactams for the initial, empirical, treatment of febrile neutropenia: comparison of beta-lactams.
|
Cochrane Database Syst Rev
|
2010
|
0.92
|
|
67
|
Empirical antifungal therapy for patients with neutropenia and persistent fever: Systematic review and meta-analysis.
|
Eur J Cancer
|
2008
|
0.92
|
|
68
|
Antibiotics for preventing meningococcal infections.
|
Cochrane Database Syst Rev
|
2011
|
0.91
|
|
69
|
Empiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adults.
|
Cochrane Database Syst Rev
|
2012
|
0.91
|
|
70
|
Co-trimoxazole versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteraemia: a retrospective cohort study.
|
J Antimicrob Chemother
|
2010
|
0.91
|
|
71
|
Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB).
|
Cochrane Database Syst Rev
|
2012
|
0.91
|
|
72
|
Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropenia.
|
Cochrane Database Syst Rev
|
2013
|
0.90
|
|
73
|
Immunoglobulin prophylaxis in hematological malignancies and hematopoietic stem cell transplantation.
|
Cochrane Database Syst Rev
|
2008
|
0.90
|
|
74
|
Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB).
|
Cochrane Database Syst Rev
|
2009
|
0.90
|
|
75
|
Propensity-matched analysis of appropriate empirical antibiotic treatment.
|
Clin Infect Dis
|
2007
|
0.89
|
|
76
|
Interventions for alleviating cancer-related dyspnea: a systematic review and meta-analysis.
|
Acta Oncol
|
2012
|
0.89
|
|
77
|
Diagnostic accuracy of PCR alone compared to galactomannan in bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis: a systematic review.
|
J Clin Microbiol
|
2012
|
0.88
|
|
78
|
The epidemiology of bacteremia with febrile neutropenia: experience from a single center, 1988-2004.
|
Isr Med Assoc J
|
2007
|
0.88
|
|
79
|
Combination antimicrobial treatment versus monotherapy: the contribution of meta-analyses.
|
Infect Dis Clin North Am
|
2009
|
0.87
|
|
80
|
Empirical antibiotics targeting Gram-positive bacteria for the treatment of febrile neutropenic patients with cancer.
|
Cochrane Database Syst Rev
|
2014
|
0.85
|
|
81
|
Antiviral prophylaxis in haematological patients: systematic review and meta-analysis.
|
Eur J Cancer
|
2009
|
0.85
|
|
82
|
Rituximab as maintenance therapy for patients with follicular lymphoma.
|
Cochrane Database Syst Rev
|
2009
|
0.83
|
|
83
|
Infection-control interventions for cancer patients after chemotherapy: a systematic review and meta-analysis.
|
Lancet Infect Dis
|
2008
|
0.82
|
|
84
|
Antibiotic treatment for cystitis.
|
Br J Gen Pract
|
2002
|
0.81
|
|
85
|
Screening for colorectal cancer: decisions in general practice.
|
Br J Gen Pract
|
2004
|
0.81
|
|
86
|
Sternal wound infection after coronary artery bypass graft surgery: validation of existing risk scores.
|
J Thorac Cardiovasc Surg
|
2007
|
0.81
|
|
87
|
Surveillance of infectious complications in hemato-oncological patients.
|
Isr Med Assoc J
|
2009
|
0.81
|
|
88
|
Duration of antibiotic prophylaxis for cardiac surgery: prospective observational study.
|
J Infect
|
2009
|
0.80
|
|
89
|
Characteristics of initial compared with subsequent bacterial infections among hospitalised haemato-oncological patients.
|
Int J Antimicrob Agents
|
2012
|
0.80
|
|
90
|
Assessing ethics of trials in systematic reviews.
|
BMJ
|
2004
|
0.80
|
|
91
|
Participation of elderly adults in randomized controlled trials addressing antibiotic treatment of pneumonia.
|
J Am Geriatr Soc
|
2015
|
0.80
|
|
92
|
Healthcare-associated vs. hospital-acquired Staphylococcus aureus bacteremia.
|
Int J Infect Dis
|
2012
|
0.79
|
|
93
|
Time to first antibiotic dose for patients hospitalised with community-acquired pneumonia.
|
Int J Antimicrob Agents
|
2013
|
0.79
|
|
94
|
Subcutaneous versus intravenous granulocyte colony stimulating factor for the treatment of neutropenia in hospitalized hemato-oncological patients: randomized controlled trial.
|
Am J Hematol
|
2014
|
0.79
|
|
95
|
Editorial commentary: combination therapy for Pseudomonas aeruginosa bacteremia: where do we stand?
|
Clin Infect Dis
|
2013
|
0.79
|
|
96
|
Systematic reviews and meta-analysis of febrile neutropenia.
|
Mayo Clin Proc
|
2005
|
0.79
|
|
97
|
Does sex affect 30-day mortality in Staphylococcus aureus bacteremia?
|
Gend Med
|
2012
|
0.79
|
|
98
|
Prediction of specific pathogens in patients with sepsis: evaluation of TREAT, a computerized decision support system.
|
J Antimicrob Chemother
|
2007
|
0.79
|
|
99
|
Clinical effectiveness of seasonal influenza vaccine among adult cancer patients.
|
Cancer
|
2013
|
0.79
|
|
100
|
Predictors for anaerobic bacteraemia beyond the source of infection: retrospective, nested, case-control study.
|
Scand J Infect Dis
|
2009
|
0.78
|
|
101
|
Tigecycline and overall mortality.
|
Clin Infect Dis
|
2012
|
0.78
|
|
102
|
Seven-year study of bacteremia in hospitalized patients on chronic hemodialysis in a single tertiary hospital.
|
Ren Fail
|
2003
|
0.78
|
|
103
|
Prediction of bacteremia using TREAT, a computerized decision-support system.
|
Clin Infect Dis
|
2006
|
0.78
|
|
104
|
Elevation of inflammatory markers in patients with systemic lupus erythematosus is associated with poorer outcome.
|
Biomed Pharmacother
|
2012
|
0.78
|
|
105
|
Low molecular weight heparin (LMWH) for primary thrombo-prophylaxis in patients with solid malignancies - systematic review and meta-analysis.
|
Acta Oncol
|
2014
|
0.77
|
|
106
|
Excess mortality related to cefepime.
|
Lancet Infect Dis
|
2010
|
0.77
|
|
107
|
Meta-analysis of a possible signal of increased mortality associated with cefepime use.
|
Clin Infect Dis
|
2010
|
0.77
|
|
108
|
Antibiotics for asymptomatic bacteriuria.
|
Cochrane Database Syst Rev
|
2015
|
0.76
|
|
109
|
Presentation of infection in older patients--a prospective study.
|
Ann Med
|
2015
|
0.76
|
|
110
|
Antibiotics for preventing meningococcal infections.
|
Cochrane Database Syst Rev
|
2013
|
0.76
|
|
111
|
Benefit associated with appropriate antibiotic treatment.
|
Clin Infect Dis
|
2007
|
0.76
|
|
112
|
Antibiotics for spontaneous bacterial peritonitis in cirrhotic patients.
|
Cochrane Database Syst Rev
|
2009
|
0.76
|
|
113
|
A stochastic model of susceptibility to antibiotic therapy--The effects of cross-resistance and treatment history.
|
Artif Intell Med
|
2007
|
0.76
|
|
114
|
Odds ratios are contingent on event rates.
|
Crit Care Med
|
2010
|
0.75
|
|
115
|
Chlamydia pneumoniae and acute coronary syndrome.
|
N Engl J Med
|
2005
|
0.75
|
|
116
|
Comment on guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK.
|
J Antimicrob Chemother
|
2006
|
0.75
|
|
117
|
Community acquired pneumonia: Antibiotic coverage is atypical: evidence from randomised trials.
|
BMJ
|
2007
|
0.75
|
|
118
|
ACP Journal Club: some antimicrobials increased admissions and ED visits for hypoglycemia in older users of glipizide or glyburide.
|
Ann Intern Med
|
2015
|
0.75
|
|
119
|
Atypical coverage for community-acquired pneumonia.
|
Am J Respir Crit Care Med
|
2007
|
0.75
|
|
120
|
Learning susceptibility of a pathogen to antibiotics using data from similar pathogens.
|
Methods Inf Med
|
2009
|
0.75
|
|
121
|
Quality of Reporting Nutritional Randomized Controlled Trials in Patients With Cystic Fibrosis.
|
J Pediatr Gastroenterol Nutr
|
2016
|
0.75
|
|
122
|
Cefepime and all-cause mortality.
|
Clin Infect Dis
|
2009
|
0.75
|
|
123
|
Changing needs of community-acquired bacterial pneumonia: experience with ceftaroline fosamil. Preface.
|
J Antimicrob Chemother
|
2011
|
0.75
|
|
124
|
The role of ¹⁸F-FDG PET/CT for the diagnosis of infections in patients with hematological malignancies and persistent febrile neutropenia.
|
Leuk Res
|
2013
|
0.75
|
|
125
|
Back to the basics: epidemiology in the Journal of Antimicrobial Chemotherapy.
|
J Antimicrob Chemother
|
2006
|
0.75
|
|
126
|
An essential requirement for the licensing of new antibiotics is the provision of data on efficacy and safety obtained from clinical trials in which patients are randomized to receive either the experimental drug or a comparator antibiotic regarded as a standard treatment option. Preface.
|
J Antimicrob Chemother
|
2013
|
0.75
|
|
127
|
Corticosteroids for pneumonia.
|
Cochrane Database Syst Rev
|
2017
|
0.75
|
|
128
|
Randomized controlled trials in the Journal of Antimicrobial Chemotherapy.
|
J Antimicrob Chemother
|
2008
|
0.75
|
|
129
|
Performance of the TREAT decision support system in an environment with a low prevalence of resistant pathogens.
|
J Antimicrob Chemother
|
2008
|
0.75
|